Company intelligence / Profile preview

CoMind Technologies

London, England, United Kingdomcomind.io ↗

Ownership: Private
Employees: ~48
Development stage: Preclinical

Overview

CoMind Technologies develops non-invasive neurotechnology devices designed to measure and monitor a wide range of neurophysiological signals at the patient’s bedside. The company aims to provide clinicians with access to critical brain data that are currently inaccessible through existing technologies. No published clinical results as of June 2025. Financial filings indicate active R&D investment and growth in staff but do not mention product commercialization or regulatory approvals yet. No peer-reviewed clinical trial outcomes found.

Therapeutic areas: Neurology
Modalities: DeviceNon-pharmacological therapy (non-invasive neuromonitoring device)
Industry: Physiological Monitoring

Beyond the preview

Go deeper on CoMind Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CoMind Technologies.

Explore the full profile